+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
Immune Thrombocytopenia Drugs - Global Strategic Business Report - Product Thumbnail Image

Immune Thrombocytopenia Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 384 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 182 Pages
  • Global
From
Fibrin Sealants - Global Strategic Business Report - Product Thumbnail Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • November 2025
  • 372 Pages
  • Global
From
Bleeding Disorder Drugs - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs - Global Strategic Business Report

  • Report
  • November 2025
  • 488 Pages
  • Global
From
Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
From
Loading Indicator